Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-001178

Chief Patient Supply Officer sold 1,065 shares at $5.33 ($5,674)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lunger John Chief Patient Supply Officer 2021-01-04 Sale −1,065 $5.33 $5,674 1,760 D: show line 1 in the form
Open-market sales · 1,065 sh · avg $5.33 · $5,674
Loading xslF345X03/tm211506d4_4seq1.xml…